Donati Francescamaria, Cioni Dania, Guarino Salvatore, Mazzeo Maria Letizia, Neri Emanuele, Boraschi Piero
Department of Diagnostic, Interventional Radiology and Nuclear Medicine, Pisa University Hospital, Via Paradisa 2, 56124 Pisa, Italy.
Academic Radiology, Department of Translational Research, University of Pisa, Via Roma 67, 56126 Pisa, Italy.
Diagnostics (Basel). 2022 Mar 31;12(4):867. doi: 10.3390/diagnostics12040867.
Chemotherapy-induced liver injury has been found to be quite common in cancer patients undergoing chemotherapy. Being aware of chemotherapy-induced hepatotoxicity is important for avoiding errors in detecting liver metastases and for defining the most appropriate clinical management strategy. MRI imaging has proven to be a useful troubleshooting tool that helps overcome false negatives in tumor response imaging after chemotherapy due to liver parenchyma changes. The purpose of this review is, therefore, to describe the characteristics of magnetic resonance imaging of the broad spectrum of liver damage induced by systemic chemotherapeutic agents in order to avoid misdiagnoses of liver metastases and disease progression and to define the most appropriate clinical management strategy.
化疗引起的肝损伤在接受化疗的癌症患者中相当常见。了解化疗引起的肝毒性对于避免在检测肝转移时出现错误以及确定最合适的临床管理策略非常重要。磁共振成像(MRI)已被证明是一种有用的故障排除工具,有助于克服化疗后由于肝实质变化导致的肿瘤反应成像中的假阴性。因此,本综述的目的是描述全身化疗药物引起的广泛肝损伤的磁共振成像特征,以避免肝转移和疾病进展的误诊,并确定最合适的临床管理策略。